These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1905285)

  • 1. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate.
    Evans DJ; Allison DG; Brown MR; Gilbert P
    J Antimicrob Chemother; 1991 Feb; 27(2):177-84. PubMed ID: 1905285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycle.
    Evans DJ; Brown MR; Allison DG; Gilbert P
    J Antimicrob Chemother; 1990 Apr; 25(4):585-91. PubMed ID: 2190969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-rate-independent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis; evidence for cell-cycle dependency.
    Duguid IG; Evans E; Brown MR; Gilbert P
    J Antimicrob Chemother; 1992 Dec; 30(6):791-802. PubMed ID: 1289353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth-rate on resistance of gram-negative biofilms to cetrimide.
    Evans DJ; Allison DG; Brown MR; Gilbert P
    J Antimicrob Chemother; 1990 Oct; 26(4):473-8. PubMed ID: 2254220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of ciprofloxacin against Pseudomonas aeruginosa planktonic and biofilm-derived cells.
    Marques CNH; Nelson SM
    Lett Appl Microbiol; 2019 Apr; 68(4):350-359. PubMed ID: 30740751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium Nitrite Inhibits Killing of Pseudomonas aeruginosa Biofilms by Ciprofloxacin.
    Zemke AC; Kocak BR; Bomberger JM
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
    Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
    Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
    Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.
    Kolpen M; Mousavi N; Sams T; Bjarnsholt T; Ciofu O; Moser C; Kühl M; Høiby N; Jensen PØ
    Int J Antimicrob Agents; 2016 Feb; 47(2):163-7. PubMed ID: 26774522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.
    Diver JM; Schollaardt T; Rabin HR; Thorson C; Bryan LE
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1538-46. PubMed ID: 1656866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.
    Bedard J; Chamberland S; Wong S; Schollaardt T; Bryan LE
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1457-64. PubMed ID: 2510591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Aaron SD; Kottachchi D; Ferris WJ; Vandemheen KL; St Denis ML; Plouffe A; Doucette SP; Saginur R; Chan FT; Ramotar K
    Eur Respir J; 2004 Oct; 24(4):631-7. PubMed ID: 15459143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.